Atlas Trials

Study of Lenalidomide as a Treatment for Neuropathy Associated With Monoclonal Gammopathy of Undetermined Significance

Clinical trial NCT00665652 · TERMINATED

Trial details

NCT number
NCT00665652
Sponsor
Dartmouth-Hitchcock Medical Center
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
NeuropathyNonmalignant Monoclonal Gammopathy of Undetermined Significance (MGUS)
Start date
2008-04-01
Primary completion
2011-05-19
Enrollment
8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.